| 4SC | resminostat | Oncology |
| AADI BIOSCIENCE | FYARRO | Oncology |
| ABBOTT LABORATORIES | enavatuzumab | Oncology |
| ABBVIE | azintuxizumab | Oncology |
| ABBVIE | azintuxizumab vedotin | Oncology |
| ABBVIE | budigalimab | Oncology |
| ABBVIE | cedirogant | Oncology |
| ABBVIE | depatuxizumab | Oncology |
| ABBVIE | depatuxizumab mafodotin | Oncology |
| ABBVIE | eftozanermin alfa | Oncology |
| ABBVIE | elotuzumab | Oncology |
| ABBVIE | giloralimab | Oncology |
| ABBVIE | ilorasertib | Oncology |
| ABBVIE | linifanib | Oncology |
| ABBVIE | livmoniplimab | Oncology |
| ABBVIE | mirzotamab | Oncology |
| ABBVIE | mirzotamab clezutoclax | Oncology |
| ABBVIE | navitoclax | Oncology |
| ABBVIE | revdofilimab | Oncology |
| ABBVIE | rizankizumab | Oncology |
| ABBVIE | rolinsatamab | Oncology |
| ABBVIE | rolinsatamab talirine | Oncology |
| ABBVIE | rovalpituzumab | Oncology |
| ABBVIE | rovalpituzumab tesirine | Oncology |
| ABBVIE | samrotamab | Oncology |
| ABBVIE | samrotamab vedotin | Oncology |
| ABBVIE | serclutamab | Oncology |
| ABBVIE | serclutamab talirine | Oncology |
| ABBVIE | tamrintamab | Oncology |
| ABBVIE | tamrintamab pamozirineab | Oncology |
| ABBVIE | telisotuzumab | Oncology |
| ABBVIE | telisotuzumab vedotin | Oncology |
| ABBVIE | veliparib | Oncology |
| ABBVIE | venetoclax | Oncology |
| ACCORD HEALTHCARE | CAMCEVI | Oncology |
| ACERTA PHARMA | acalabrutinib | Oncology |
| ACERTA PHARMA | CALQUENCE * | Oncology |
| ACETYLON PHARMACEUTICALS | ricolinostat | Oncology |
| ACTINIUM | actinium (225ac) lintuzumab satetraxetan | Oncology |
| ACTINIUM | iodine (131i) apamistamab | Oncology |
| ACTUATE THERAPEUTICS | elraglusib | Oncology |
| ADAPTIMMUNE | afamitresgene autoleucel | Oncology |
| ADAPTIMMUNE | afamitresgene autoleucel | Oncology |
| ADAPTIMMUNE | letetresgene autoleucel | Oncology |
| ADAPTIMMUNE | olitresgene autoleucel | Oncology |
| ADC THERAPEUTICS | camidanlumab | Oncology |
| ADC THERAPEUTICS | camidanlumab tesirine | Oncology |
| ADC THERAPEUTICS | loncastuximab | Oncology |
| ADC THERAPEUTICS | loncastuximab tesirine | Oncology |
| ADC THERAPEUTICS | mipasetamab | Oncology |
| ADC THERAPEUTICS | mipasetamab uzoptirine | Oncology |
| ADC THERAPEUTICS | ZYNLONTA * | Oncology |
| ADVANCED ACCELERATOR APPLICATIONS | LOCAMETZ | Oncology |
| ADVAXIS | axalimogene filolisbac | Oncology |
| ADVAXIS | capolimogene apralisbac | Oncology |
| AFFIBODY | tezatabep matraxetan | Oncology |
| AGENUS | botensilimab | Oncology |
| AGIOS PHARMACEUTICALS | enasidenib | Oncology |
| AGIOS PHARMACEUTICALS | ivosidenib | Oncology |
| AGIOS PHARMACEUTICALS | vorasidenib | Oncology |
| AGIOS PHARMACEUTICALS | vorasidenib citrate | Oncology |
| AILERON THERAPEUTICS | sulanemadlin | Oncology |
| ALEXION PHARMACEUTICALS | cerdulatinib | Oncology |
| ALKERMES | nemvaleukin alfa | Oncology |
| AMGEN | acapatamab | Oncology |
| AMGEN | alsevalimab | Oncology |
| AMGEN | bemarituzumab | Oncology |
| AMGEN | bevacizumab beta | Oncology |
| AMGEN | BLINCYTO ((ビーリンサイト) * | Oncology |
| AMGEN | cabiralizumab | Oncology |
| AMGEN | eluvixtamab | Oncology |
| AMGEN | emerfetamab | Oncology |
| AMGEN | emirodatamab | Oncology |
| AMGEN | etevritamab | Oncology |
| AMGEN | gresonitamab | Oncology |
| AMGEN | inezetamab | Oncology |
| AMGEN | KANJINTI * | Oncology |
| AMGEN | KYPROLIS * | Oncology |
| AMGEN | latikafusp | Oncology |
| AMGEN | LUMAKRAS | Oncology |
| AMGEN | LUMYKRAS | Oncology |
| AMGEN | murizatoclax | Oncology |
| AMGEN | MVASI * | Oncology |
| AMGEN | oprozomib | Oncology |
| AMGEN | pacanalotamab | Oncology |
| AMGEN | pavurutamab | Oncology |
| AMGEN | sotorasib | Oncology |
| AMGEN | sovilnesib | Oncology |
| AMGEN | tapotoclax | Oncology |
| AMGEN | tarlatamab | Oncology |
| AMGEN | trebananib | Oncology |
| AMGEN | vepsitamab | Oncology |
| AMGEN | xaluritamig | Oncology |
| AMGEN | XGEVA | Oncology |
| AMGEN | zeluvalimab | Oncology |
| AMNEAL PHARMACEUTICALS | ALYMSYS * | Oncology |
| AMPHIVENA THERAPEUTICS | vixtimotamab | Oncology |
| ANHEART THERAPEUTICS | taletrectinib | Oncology |
| ANHEART THERAPEUTICS | taletrectinib adipate | Oncology |
| APEIRON BIOLOGICS | lorukafusp alfa | Oncology |
| APOTEX | docetaxel | Oncology |
| APREA THERAPEUTICS | eprenetapopt | Oncology |
| ARCUS BIOSCIENCES | domvanalimab | Oncology |
| ARCUS BIOSCIENCES | etrumadenant | Oncology |
| ARCUS BIOSCIENCES | quemliclustat | Oncology |
| ARCUS BIOSCIENCES | ralzapastotug | Oncology |
| ARCUS BIOSCIENCES | zimberelimab | Oncology |
| ARIAD PHARMACEUTICALS | ALUNBRIG | Oncology |
| ARIAD PHARMACEUTICALS | ICLUSIG | Oncology |
| ARIAD PHARMACEUTICALS | ponatinib | Oncology |
| ARIAD PHARMACEUTICALS | ponatinib hydrochloride | Oncology |
| ARIVIVE | batiraxcept | Oncology |
| ARVINAS | bavdegalutamide | Oncology |
| ASCENTAGE PHARMA | alrizomadlin | Oncology |
| ASCENTAGE PHARMA | lisaftoclax | Oncology |
| ASCENTAGE PHARMA | olverembatinib | Oncology |
| ASCENTAGE PHARMA | pelcitoclax | Oncology |
| ASTELLAS | gilteritinib | Oncology |
| ASTELLAS | torulimogene lonferencel | Oncology |
| ASTELLAS | XTANDI | Oncology |
| ASTELLAS | zolbetuximab | Oncology |
| ASTELLAS ONCOLOGY | XOSPATA * | Oncology |
| ASTEX PHARMACEUTICALS | cedazuridine | Oncology |
| ASTEX PHARMACEUTICALS | guadecitabine | Oncology |
| ASTEX PHARMACEUTICALS | INQOVI * | Oncology |
| ASTRAZENECA | acalabrutinib | Oncology |
| ASTRAZENECA | adavosertib | Oncology |
| ASTRAZENECA | bicalutamide | Oncology |
| ASTRAZENECA | camizestrant | Oncology |
| ASTRAZENECA | capivasertib | Oncology |
| ASTRAZENECA | CAPRELSA | Oncology |
| ASTRAZENECA | CASODEX | Oncology |
| ASTRAZENECA | CASODEX OD
(カソデックスＯＤ) | Oncology |
| ASTRAZENECA | ceralasertib | Oncology |
| ASTRAZENECA | danvatirsen | Oncology |
| ASTRAZENECA | defosbarasertib | Oncology |
| ASTRAZENECA | ENHERTU | Oncology |
| ASTRAZENECA | FASLODEX * | Oncology |
| ASTRAZENECA | IRESSA * | Oncology |
| ASTRAZENECA | KOSELUGO * | Oncology |
| ASTRAZENECA | LUMOXITI | Oncology |
| ASTRAZENECA | rilvegostomig | Oncology |
| ASTRAZENECA | savolitinib | Oncology |
| ASTRAZENECA | selumetinib | Oncology |
| ASTRAZENECA | selumetinib sulfate | Oncology |
| ASTRAZENECA | TAGRISSO (Тагриссо) * | Oncology |
| ASTRAZENECA | telratolimod | Oncology |
| ASTRAZENECA | ZOLADEX | Oncology |
| ATEA PHARMACEUTICALS | bemnifosbuvir | Oncology |
| ATEA PHARMACEUTICALS | bemnifosbuvir sulfate | Oncology |
| ATHENEX | encequidar | Oncology |
| ATHENEX | tirbanibulin | Oncology |
| ATRIX LABORATORIES | ELIGARD * | Oncology |
| AURINIA PHARMACEUTICALS | terameprocol | Oncology |
| AUTOLUS THERAPEUTICS | dalucabtagene autoleucel | Oncology |
| AUTOLUS THERAPEUTICS | obecabtagene autoleucel | Oncology |
| AVELAS BIOSCIENCES | pegloprastide | Oncology |
| BASILEA PHARMACEUTICA | avanbulin | Oncology |
| BASILEA PHARMACEUTICA | lisavanbulin | Oncology |
| BAYER | ALIQOPA * | Oncology |
| BAYER | aprutumab | Oncology |
| BAYER | aprutumab ixadotin | Oncology |
| BAYER | copanlisib | Oncology |
| BAYER | darolutamide | Oncology |
| BAYER | NEXAVAR * | Oncology |
| BAYER | NUBEQA (ニュベクオ) | Oncology |
| BAYER | radretumab | Oncology |
| BAYER | refametinib | Oncology |
| BAYER | roniciclib | Oncology |
| BAYER | sorafenib | Oncology |
| BAYER | VIADUR | Oncology |
| BAYER | VITRAKVI * | Oncology |
| BAYER | XOFIGO | Oncology |
| BAYER | XOFIGO (RADIUM RA 223 DICHLORIDE) | Oncology |
| BEIGENE | BRUKINSA * | Oncology |
| BEIGENE | garivulimab | Oncology |
| BEIGENE | lifirafenib | Oncology |
| BEIGENE | ociperlimab | Oncology |
| BEIGENE | pamiparib | Oncology |
| BEIGENE | surzebiclimab | Oncology |
| BEIGENE | tislelizumab | Oncology |
| BEIGENE | zanubrutinib | Oncology |
| BELLICUM PHARMACEUTICALS | rimiducid | Oncology |
| BERGEN BIO | bemcentinib | Oncology |
| BERGEN BIO | tilvestamab | Oncology |
| BETA PHARMA | eciruciclib | Oncology |
| BETA PHARMA | rezivertinib | Oncology |
| BETACAT | tegavivint | Oncology |
| BEYONDBIO | avotaciclib | Oncology |
| BIO-PATH HOLDINGS | prexigebersen | Oncology |
| BIOCANCELL THERAPEUTICS | inodiftagene vixteplasmid | Oncology |
| BIOGEN | RITUXAN | Oncology |
| BIOINVENT INTERNATIONAL | bersanlimab | Oncology |
| BIOLINE RX | motixafortide | Oncology |
| BIOMED VALLEY | ulixertinib | Oncology |
| BIONOVUS LIFE SCIENCES | fosciclopirox | Oncology |
| BIONUMERIK PHARMACEUTICALS | TAVOCEPT | Oncology |
| BIOSIGHT | aspacytarabine | Oncology |
| BIPAR | iniparib | Oncology |
| BLACK DIAMOND | tuxobertinib | Oncology |
| BLAZE BIOSCIENCE | tozuleristide | Oncology |
| BLUE EARTH DIAGNOSTICS | flotufolastat (18f) * | Oncology |
| BLUE EARTH DIAGNOSTICS | flotufolastat f 18 gallium | Oncology |
| BLUEPRINT MEDICINES | avapritinib | Oncology |
| BLUEPRINT MEDICINES | AYVAKIT | Oncology |
| BLUEPRINT MEDICINES | fisogatinib | Oncology |
| BLUEPRINT MEDICINES | pralsetinib | Oncology |
| BOEHRINGER INGELHEIM | GILOTRIF | Oncology |
| BOEHRINGER INGELHEIM | GIOTRIF | Oncology |
| BOSTON PHARMACEUTICALS | zeteletinib | Oncology |
| BOSTON PHARMACEUTICALS | zeteletinib adipate | Oncology |
| BRII BIOSCIENCES | amubarvimab | Oncology |
| BRISTOL MYERS SQUIBB | alvespimycin | Oncology |
| BRISTOL MYERS SQUIBB | alvespimycin hydrochloride | Oncology |
| BRISTOL MYERS SQUIBB | amrubicin hydrochloride | Oncology |
| BRISTOL MYERS SQUIBB | BREYANZI * | Oncology |
| BRISTOL MYERS SQUIBB | ISTODAX * | Oncology |
| BRISTOL MYERS SQUIBB | onatasertib | Oncology |
| BRISTOL MYERS SQUIBB | onatasertib | Oncology |
| BRISTOL MYERS SQUIBB | OPDUALAG | Oncology |
| BRISTOL MYERS SQUIBB | orvacabtagene autoleucel | Oncology |
| BRISTOL MYERS SQUIBB | pomalidomide | Oncology |
| BRISTOL MYERS SQUIBB | tanespimycin | Oncology |
| BRISTOL MYERS SQUIBB | vadacabtagene leraleucel | Oncology |
| BRISTOL MYERS SQUIBB | vadacabtagene leraleucel | Oncology |
| BRISTOL MYERS SQUIBB | VIDAZA | Oncology |
| CALITHERA | telaglenastat | Oncology |
| CANTEX PHARMACEUTICALS | dociparstat | Oncology |
| CASI PHARMACEUTICALS | PANZEM | Oncology |
| CASI PHARMACEUTICALS | PROMUNE | Oncology |
| CELLID | vibapapogene autoleucel | Oncology |
| CELLTRION HEALTHCARE | BLITZIMA | Oncology |
| CELLTRION HEALTHCARE | HERZUMA | Oncology |
| CELLTRION HEALTHCARE | RITEMVIA | Oncology |
| CELLTRION HEALTHCARE | TRUXIMA | Oncology |
| CELLTRION HEALTHCARE | TUXELLA | Oncology |
| CELLTRION HEALTHCARE | VEGZELMA | Oncology |
| CEPTARIS THERAPEUTICS | VALCHLOR * | Oncology |
| CERULEAN | davamotecan pegadexamer | Oncology |
| CHECKPOINT THERAPEUTICS | cosibelimab | Oncology |
| CHECKPOINT THERAPEUTICS | olafertinib | Oncology |
| CHINOOK THERAPEUTICS | damistimagene matitucel | Oncology |
| CHINOOK THERAPEUTICS | enistimagene setitucel | Oncology |
| CHONG KUN DANG | alteminostat | Oncology |
| CHONG KUN DANG | valecobulin | Oncology |
| CHUGAI PHARMA | ALECENSA * | Oncology |
| CHUGAI PHARMA | ROZLYTREK (ロズリートレク) | Oncology |
| CLOVIS ONCOLOGY | rociletinib | Oncology |
| CLOVIS ONCOLOGY | RUBRACA * | Oncology |
| CONSTELLATION PHARMACEUTICALS | lirametostat | Oncology |
| CONSTELLATION PHARMACEUTICALS | pelabresib | Oncology |
| CONSTELLATION PHARMACEUTICALS | tulmimetostat | Oncology |
| CRISPR | evoncabtagene pazurgedleucel | Oncology |
| CRISPR THERAPEUTICS | motacabtagene lurevgedleucel | Oncology |
| CRISPR THERAPEUTICS | volamcabtagene durzigedleucel | Oncology |
| CULLINAN ONCOLOGY | zipalertinib | Oncology |
| CURIS | emavusertib | Oncology |
| CURIS | emavusertib hydrochloride | Oncology |
| CURIS | emavusertib maleate | Oncology |
| CURIS | emavusertib mesylate | Oncology |
| CURIS | emavusertib phosphate | Oncology |
| CURIS | emavusertib tosylate | Oncology |
| CUROCELL | anbalcabtagene autoleucel | Oncology |
| CYTOMX THERAPEUTICS | pacmilimab | Oncology |
| CYTOMX THERAPEUTICS | praluzatamab | Oncology |
| CYTOMX THERAPEUTICS | praluzatamab ravtansine | Oncology |
| DAIICHI SANKYO | datopotamab | Oncology |
| DAIICHI SANKYO | datopotamab deruxtecan | Oncology |
| DAIICHI SANKYO | ENHERTU (エンハーツ) | Oncology |
| DAIICHI SANKYO | EZHARMIA | Oncology |
| DAIICHI SANKYO | patritumab | Oncology |
| DAIICHI SANKYO | pexidartinib | Oncology |
| DAIICHI SANKYO | safusidenib | Oncology |
| DAIICHI SANKYO | tivantinib | Oncology |
| DAIICHI SANKYO | TURALIO * | Oncology |
| DAIICHI SANKYO | VANFLYTA (ヴァンフリタ) * | Oncology |
| DECIPHERA PHARMACEUTICALS | QINLOCK * | Oncology |
| DECIPHERA PHARMACEUTICALS | QINLOCK * | Oncology |
| DECIPHERA PHARMACEUTICALS | vimseltinib | Oncology |
| DEKK-TEC | mipicoledine | Oncology |
| DENDREON | lapuleucel-t | Oncology |
| DENDREON | PROVENGE | Oncology |
| DENDREON | sipuleucel-t | Oncology |
| DNATRIX | tezemlimogene daxadenorepvec | Oncology |
| DNATRIX, INC. | tasadenoturev | Oncology |
| DOT-THERAPEUTICS-1 | tovorafenib | Oncology |
| DR. REDDY'S LAB | ESAMUZE | Oncology |
| DR. REDDY'S LAB | HERVYCTA | Oncology |
| EAGLE PHARMACEUTICALS | BELRAPZO | Oncology |
| EAGLE PHARMACEUTICALS | BENDEKA * | Oncology |
| EFFECTOR | tomivosertib | Oncology |
| EFFECTOR | zotatifin | Oncology |
| EISAI | DACOGEN | Oncology |
| EISAI | HALAVEN | Oncology |
| EISAI | KISPLYX | Oncology |
| EISAI | LENVIMA | Oncology |
| EMD SERONO | evobrutinib | Oncology |
| ENZYCHEM | mosedipimod | Oncology |
| EPIZYME | pinometostat | Oncology |
| EPIZYME | tazemetostat | Oncology |
| EPIZYME | TAZVERIK * | Oncology |
| EQRX | aumolertinib | Oncology |
| EQRX | aumolertinib mesylate | Oncology |
| ERIMOS PHARMACEUTICALS | terameprocol | Oncology |
| EUSA PHARMA | QARZIBA | Oncology |
| EXELIXIS | cabozantinib | Oncology |
| EXELIXIS | zanzalintinib | Oncology |
| FORMA THERAPEUTICS | REZLIDHIA | Oncology |
| FORSEE PHARMACEUTICALS | CAMCEVI KIT | Oncology |
| GALERA THERAPEUTICS | rucosopasem manganese | Oncology |
| GAMAMABS | murlentamab | Oncology |
| GEISTLICH PHARMA | misetionamide | Oncology |
| GENEMEDICINE | opilrelagene atradenorepvec | Oncology |
| GENENTECH | ALECENSA * | Oncology |
| GENENTECH | atezolizumab | Oncology |
| GENENTECH | autogene cevumeran | Oncology |
| GENENTECH | autogene cevumeran | Oncology |
| GENENTECH | AVASTIN * | Oncology |
| GENENTECH | cevostamab | Oncology |
| GENENTECH | cobimetinib | Oncology |
| GENENTECH | dulanermin | Oncology |
| GENENTECH | duligotuzumab | Oncology |
| GENENTECH | GAZYVA * | Oncology |
| GENENTECH | HERCEPTIN HYLECTA * | Oncology |
| GENENTECH | ipatasertib | Oncology |
| GENENTECH | KADCYLA (カドサイラ) | Oncology |
| GENENTECH | mosunetuzumab | Oncology |
| GENENTECH | PERJETA (パージェタ) * | Oncology |
| GENENTECH | pinatuzumab vedotin | Oncology |
| GENENTECH | polatuzumab vedotin | Oncology |
| GENENTECH | POLIVY * | Oncology |
| GENENTECH | RITUXAN | Oncology |
| GENENTECH | ROZLYTREK | Oncology |
| GENENTECH | runimotamab | Oncology |
| GENENTECH | TARCEVA * | Oncology |
| GENENTECH | taselisib | Oncology |
| GENENTECH | TECENTRIQ * | Oncology |
| GENENTECH | tiragolumab | Oncology |
| GENEXINE | efineptakin alfa | Oncology |
| GENEXINE | tirvalimogene teraplasmid | Oncology |
| GENMAB | ARZERRA (アーゼラ) | Oncology |
| GENMAB | TIVDAK | Oncology |
| GENMAB US | EPKINLY | Oncology |
| GENOMIC HEALTH | GENOMIC PROSTATE SCORE (GPS) | Oncology |
| GENORBIO | coprelotamab | Oncology |
| GENORBIO | geptanolimab | Oncology |
| GENTA | GENASENSE | Oncology |
| GERON | paclitaxel trevatide | Oncology |
| GILEAD | acalisib | Oncology |
| GILEAD | alobresib | Oncology |
| GILEAD | andecaliximab | Oncology |
| GILEAD | dalutrafusp alfa | Oncology |
| GILEAD | entospletinib | Oncology |
| GILEAD | epacmarstobart | Oncology |
| GILEAD | evixapodlin | Oncology |
| GILEAD | idelalisib | Oncology |
| GILEAD | magrolimab | Oncology |
| GILEAD | simtuzumab | Oncology |
| GILEAD | tilpisertib | Oncology |
| GILEAD | tirabrutinib | Oncology |
| GILEAD | vesatolimod | Oncology |
| GLENMARK PHARMACEUTICALS | telazorlimab | Oncology |
| GLYCOTOPE | gatipotuzumab | Oncology |
| GLYCOTOPE | timigutuzumab | Oncology |
| GLYCOTOPE | tomuzotuximab | Oncology |
| GSK | ARZERRA (アーゼラ) | Oncology |
| GSK | astuprotimut-r | Oncology |
| GSK | belantamab | Oncology |
| GSK | belantamab mafodotin | Oncology |
| GSK | belizatinib | Oncology |
| GSK | BEXXAR * | Oncology |
| GSK | BLENREP * | Oncology |
| GSK | CYTEFURAN | Oncology |
| GSK | encelimab | Oncology |
| GSK | feladilimab | Oncology |
| GSK | JEMPERLI * | Oncology |
| GSK | MEKINIST * | Oncology |
| GSK | molibresib | Oncology |
| GSK | omipalisib | Oncology |
| GSK | pemrametostat | Oncology |
| GSK | REZONIC | Oncology |
| GSK | TAFINLAR * | Oncology |
| GSK | uprosertib | Oncology |
| GSK | VOTRIENT * | Oncology |
| GSK | zastumotide | Oncology |
| HALOZYME THERAPEUTICS | pegvorhyaluronidase alfa | Oncology |
| HANMI PHARMACEUTICALS | belvarafenib | Oncology |
| HANMI PHARMACEUTICALS | olmutinib | Oncology |
| HANMI PHARMACEUTICALS | poseltinib | Oncology |
| HELSINN HEALTHCARE | AMIXEA | Oncology |
| HELSINN HEALTHCARE | RESSURO | Oncology |
| HOOKIPA PHARMA | esepapogene zalarnarepvec | Oncology |
| HOOKIPA PHARMA | ninsipapogene sibarnarepvec | Oncology |
| HUYA | HIYASTA | Oncology |
| I-MAB | lemzoparlimab | Oncology |
| I-MAB | uliledlimab | Oncology |
| IDEAYA BIOSCIENCES | darovasertib | Oncology |
| IDERA PHARMACEUTICALS | tilsotolimod | Oncology |
| IGNYTA | entrectinib | Oncology |
| IMMUNOCORE | KIMMTRAK * | Oncology |
| IMMUNOGEN | cantuzumab ravtansine | Oncology |
| IMMUNOGEN | laprituximab | Oncology |
| IMMUNOGEN | laprituximab emtansine | Oncology |
| IMMUNOGEN | lorvotuzumab mertansine | Oncology |
| IMMUNOGEN | mirvetuximab soravtansine | Oncology |
| IMMUNOGEN | naratuximab emtansine | Oncology |
| IMMUNOMIC THERAPEUTICS | umitrelimorgene autodencel | Oncology |
| INCYTE | PEMAZYRE * | Oncology |
| INCYTE | pemigatinib | Oncology |
| INHIBRX | enristomig | Oncology |
| INNOCRIN PHARMACEUTICALS | seviteronel | Oncology |
| INOVIO | bizalimogene ralaplasmid | Oncology |
| INOVIO | mavilimogene ralaplasmid | Oncology |
| INSPIRNA | abequolixron | Oncology |
| INSPIRNA | abequolixron zinc | Oncology |
| INSPYR THERAPEUTICS | mipsagargin | Oncology |
| INSTIL BIO | cenzileucel | Oncology |
| INTREXON | veledimex | Oncology |
| INTROGEN THERAPEUTICS | ADVEXIN * | Oncology |
| IOVANCE BIOTHERAPEUTICS | lifileucel | Oncology |
| IPR PHARMS | CAPRELSA | Oncology |
| IPSEN BIOPHARM LTD | CABOMETYX (カボメティクス) * | Oncology |
| IPSEN BIOPHARM LTD | satoreotide tetraxetan | Oncology |
| IPSEN BIOPHARM LTD | zalsenertant tetraxetan | Oncology |
| ISOFOL | arfolitixorin | Oncology |
| ISTARI ONCOLOGY | lerapolturev | Oncology |
| ISTARI ONCOLOGY | lerapolturev | Oncology |
| ISU ABXIS | barecetamab | Oncology |
| J-PHARMA | nanvuranlat | Oncology |
| JANSSEN | AKEEGA | Oncology |
| JANSSEN | amivantamab | Oncology |
| JANSSEN | apalutamide | Oncology |
| JANSSEN | BALVERSA * | Oncology |
| JANSSEN | CARVYKTI | Oncology |
| JANSSEN | cetrelimab | Oncology |
| JANSSEN | ciduvectamig | Oncology |
| JANSSEN | ciltacabtagene autoleucel | Oncology |
| JANSSEN | daratumumab | Oncology |
| JANSSEN | DARZALEX | Oncology |
| JANSSEN | DARZALEX FASPRO | Oncology |
| JANSSEN | DARZQURO | Oncology |
| JANSSEN | duvortuxizumab | Oncology |
| JANSSEN | ERLEADA | Oncology |
| JANSSEN | lazertinib | Oncology |
| JANSSEN | lorpucitinib | Oncology |
| JANSSEN | mitazalimab | Oncology |
| JANSSEN | onametostat | Oncology |
| JANSSEN | onvatilimab | Oncology |
| JANSSEN | opolimogene capmilisbac | Oncology |
| JANSSEN | pemlimogene merolisbac | Oncology |
| JANSSEN | RYBREVANT * | Oncology |
| JANSSEN | seltorexant | Oncology |
| JANSSEN | SYLVANT | Oncology |
| JANSSEN | talacotuzumab | Oncology |
| JANSSEN | talquetamab | Oncology |
| JANSSEN | teclistamab | Oncology |
| JANSSEN | TECVALYI * | Oncology |
| JANSSEN | voxalatamab | Oncology |
| JANSSEN | YONDELIS * | Oncology |
| JANSSEN | ZYTIGA (Зитига) * | Oncology |
| JANSSEN-CILAG INTERNATIONAL NV | TECVAYLI | Oncology |
| JAZZ PHARMACEUTICALS | pegcrisantaspase | Oncology |
| JAZZ PHARMACEUTICALS | RYLAZE * | Oncology |
| JAZZ PHARMACEUTICALS | VYXEOS * | Oncology |
| JAZZ PHARMACEUTICALS | ZEPZELCA * | Oncology |
| JEIL PHARMACEUTICAL | nesuparib | Oncology |
| JOHNSON & JOHNSON | carlumab | Oncology |
| JOHNSON & JOHNSON | intetumumab | Oncology |
| JOHNSON & JOHNSON | quisinostat | Oncology |
| JOHNSON & JOHNSON | serdemetan | Oncology |
| JOHNSON & JOHNSON | siltuximab | Oncology |
| JOHNSON & JOHNSON | talmapimod | Oncology |
| JOUNCE THERAPEUTICS | pimivalimab | Oncology |
| JOUNCE THERAPEUTICS | polzastobart | Oncology |
| JOUNCE THERAPEUTICS | vopratelimab | Oncology |
| JW PHARMACEUTICAL | relmacabtagene autoleucel | Oncology |
| JW THERAPEUTICS | lisocabtagene maraleucel | Oncology |
| KARTOS | navtemadlin | Oncology |
| KARYOPHARM | NEXPOVIO * | Oncology |
| KARYOPHARM | selinexor | Oncology |
| KARYOPHARM | XPOVIO * | Oncology |
| KARYOPHARM THERAPEUTICS | padnarsertib | Oncology |
| KINNATE BIOPHARMA | exarafenib | Oncology |
| KURA ONCOLOGY | edaxeterkib | Oncology |
| KURA ONCOLOGY | ziftomenib | Oncology |
| KYMAB | alomfilimab | Oncology |
| KYMAB | amlitelimab | Oncology |
| KYOWA KIRIN | POTELIGEO | Oncology |
| LEAP THERAPEUTICS | surexatamab | Oncology |
| LIGAND PHARMACEUTICALS | ONTAK | Oncology |
| LIGAND PHARMACEUTICALS | TARGRETIN * | Oncology |
| LOXO ONCOLOGY | larotrectinib | Oncology |
| LOXO ONCOLOGY | RETEVMO | Oncology |
| LOXO ONCOLOGY | selitrectinib | Oncology |
| LOXO ONCOLOGY | selpercatinib | Oncology |
| LOXO ONCOLOGY | VITRAKVI * | Oncology |
| LSK BIOPHARMA | rivoceranib | Oncology |
| LUNDBECK | ingenol disoxate | Oncology |
| LUNDBECK | TREANDA * | Oncology |
| LUNDBECK | TRISENOX * | Oncology |
| LYCERA | cintirorgon | Oncology |
| LYTIX BIOPHARMA | ruxotemitide | Oncology |
| MABXIENCE RESEARCH SL | ALYMSYS | Oncology |
| MACROGENICS | lorigerlimab | Oncology |
| MACROGENICS | lorigerlimab | Oncology |
| MACROGENICS | MARGENZA | Oncology |
| MACROGENICS | vobramitamab | Oncology |
| MACROGENICS | vobramitamab duocarmazine | Oncology |
| MARKER THERAPEUTICS | zedenoleucel | Oncology |
| MARKER THERAPEUTICS | zedenoleucel | Oncology |
| MAST THERAPEUTICS | folitixorin | Oncology |
| MAST THERAPEUTICS | folitixorin calcium | Oncology |
| MEDICENNA THERAPEUTICS | bizaxofusp | Oncology |
| MEDIMMUNE | blinatumomab | Oncology |
| MEDIMMUNE | efgivanermin alfa | Oncology |
| MEDIMMUNE | etaracizumab | Oncology |
| MEDIMMUNE | moxetumomab pasudotox | Oncology |
| MEDIVIR | fostroxacitabine bralpamide | Oncology |
| MEI PHARMA | zandelisib | Oncology |
| MERCK & CO. | baloramotide | Oncology |
| MERCK & CO. | belzutifan | Oncology |
| MERCK & CO. | cadalimogene ixalentivec | Oncology |
| MERCK & CO. | derazantinib | Oncology |
| MERCK & CO. | derazantinib hydrochloride | Oncology |
| MERCK & CO. | KEYTRUDA | Oncology |
| MERCK & CO. | lapretolimod | Oncology |
| MERCK & CO. | miransertib | Oncology |
| MERCK & CO. | nemtabrutinib | Oncology |
| MERCK & CO. | pembrolizumab | Oncology |
| MERCK & CO. | SYLATRON | Oncology |
| MERCK & CO. | TEMODAR * | Oncology |
| MERCK & CO. | vevorisertib | Oncology |
| MERCK & CO. | ZOLINZA | Oncology |
| MERCK SHARP DOHME | WELIREG | Oncology |
| MEREO BIOPHARM | brontictuzumab | Oncology |
| MEREO BIOPHARM | demcizumab | Oncology |
| MEREO BIOPHARM | efaprinermin alfa | Oncology |
| MEREO BIOPHARM | etigilimab | Oncology |
| MEREO BIOPHARM | ipafricept | Oncology |
| MEREO BIOPHARM | navicixizumab | Oncology |
| MEREO BIOPHARM | rosmantuzumab | Oncology |
| MEREO BIOPHARM | tarextumab | Oncology |
| MEREO BIOPHARM | vantictumab | Oncology |
| MERUS | zenocutuzumab | Oncology |
| MILTENYI | zamtocabtagene autoleucel | Oncology |
| MIRATI THERAPEUTICS | adagrasib | Oncology |
| MIRATI THERAPEUTICS | glesatinib | Oncology |
| MIRATI THERAPEUTICS | KRAZATI * | Oncology |
| MIRATI THERAPEUTICS | mocetinostat | Oncology |
| MIRATI THERAPEUTICS | mocetinostat dihydrobromide | Oncology |
| MIRATI THERAPEUTICS | sitravatinib | Oncology |
| MODERNA | acavameran | Oncology |
| MOLECULAR TEMPLATES | molecular templates | Oncology |
| MOLOGEN | lefitolimod | Oncology |
| MONOPAR | camsirubicin | Oncology |
| MORPHOSYS | felzartamab | Oncology |
| MORPHOSYS | tafasitamab | Oncology |
| MUNDIPHARMA | DIFOLTA | Oncology |
| MUNDIPHARMA | tinostamustine | Oncology |
| MYOVANT SCIENCES | ORGOVYX | Oncology |
| MYRIAD | verubulin | Oncology |
| NANOCARRIER | demplatin pegraglumer | Oncology |
| NEKTAR | avipendekin pegol | Oncology |
| NEKTAR | bempegaldesleukin | Oncology |
| NEKTAR | etirinotecan pegol | Oncology |
| NEKTAR | etirinotecan pegol tetrahydrochloride | Oncology |
| NEKTAR | etirinotecan pegol tetratriflutate | Oncology |
| NEOGENIX ONCOLOGY | ensituximab | Oncology |
| NEWRON | XADAGO * | Oncology |
| NIPPON KAYAKU | firtecan peglumer | Oncology |
| NOVARTIS | AFINITOR | Oncology |
| NOVARTIS | AMDRAY * | Oncology |
| NOVARTIS | batoprotafib | Oncology |
| NOVARTIS | dovitinib | Oncology |
| NOVARTIS | dovitinib lactate | Oncology |
| NOVARTIS | FARYDAK * | Oncology |
| NOVARTIS | JAKAVI | Oncology |
| NOVARTIS | KYMRIAH | Oncology |
| NOVARTIS | lucatumumab | Oncology |
| NOVARTIS | ODOMZO | Oncology |
| NOVARTIS | PIQRAY * | Oncology |
| NOVARTIS | PLUVICTO | Oncology |
| NOVARTIS | rapcabtagene autoleucel | Oncology |
| NOVARTIS | RYDAPT | Oncology |
| NOVARTIS | SCEMBLIX * | Oncology |
| NOVARTIS | TABRECTA (タブレクタ) * | Oncology |
| NOVARTIS | TASIGNA | Oncology |
| NOVARTIS | tisagenlecleucel | Oncology |
| NOVARTIS | VOTUBIA | Oncology |
| NOVARTIS | ZOMETA * | Oncology |
| NOVARTIS | ZYKADIA * | Oncology |
| NOVARTIS PHARMACEUTICALS CANADA INC | TABRECTA | Oncology |
| NUCANA | fosgemcitabine palabenamide | Oncology |
| NUCANA | fosifloxuridine nafalbenamide | Oncology |
| NUVATION BIO | inixaciclib | Oncology |
| OASMIA PHARMACEUTICALS | APEALEA | Oncology |
| OCTREOPHARM | satoreotide trizoxetan | Oncology |
| ONCONOVA THERAPEUTICS | narazaciclib | Oncology |
| ONCOPEPTIDES | melphalan flufenamide | Oncology |
| ONCOPEPTIDES AB | PEPAXTI | Oncology |
| ONCOPEPTIDES AB | PEPAXTO | Oncology |
| ONCOSEC | tavokinogene telseplasmid | Oncology |
| ONCOTHERAPY SCIENCE | elpamotide | Oncology |
| ONCOTHERAPY SCIENCE | latromotide | Oncology |
| ONCOTHERAPY SCIENCE | pradimotide | Oncology |
| ONCOTHERAPYSCIENCE | tabituximab | Oncology |
| ONCOTHERAPYSCIENCE | tabituximab barzuxetan | Oncology |
| ONO PHARMACEUTICAL | tamnorzatinib | Oncology |
| ONO PHARMACEUTICALS | VELEXBRU (ベレキシブル) | Oncology |
| ONXEO | etidaligide | Oncology |
| OSCOTEC | denfivotinib | Oncology |
| OSI PHARMACEUTICALS | linsitinib | Oncology |
| OSI PHARMACEUTICALS | TARCEVA * | Oncology |
| OTSUKA PHARMACEUTICAL | INQOVI * | Oncology |
| OXIGENE | fosbretabulin | Oncology |
| OXIGENE | fosbretabulin disodium | Oncology |
| OXIGENE | fosbretabulin tromethamine | Oncology |
| PASSAGE BIO | ompenaclid | Oncology |
| PDS BIOTECHNOLOGY | pexipepimut-s | Oncology |
| PENDOPHARM | DEMYLOCAN * | Oncology |
| PENDOPHARM | ZEULIDE DEPOT * | Oncology |
| PENTIXAPHARM | gallium (68ga) boclatixafortide | Oncology |
| PENTIXAPHARM | yttrium (90y) anditixafortide | Oncology |
| PFIZER | agatolimod | Oncology |
| PFIZER | BESPONSA | Oncology |
| PFIZER | BRAFTOVI * | Oncology |
| PFIZER | DAURISMO | Oncology |
| PFIZER | elranatamab | Oncology |
| PFIZER | elranatamab | Oncology |
| PFIZER | enzalutamide | Oncology |
| PFIZER | gemtuzumab ozogamicin | Oncology |
| PFIZER | IBRANCE | Oncology |
| PFIZER | LORBRENA (ローブレナ) * | Oncology |
| PFIZER | LORVIQUA | Oncology |
| PFIZER | MEKTOVI * | Oncology |
| PFIZER | METARET | Oncology |
| PFIZER | MYLOTARG | Oncology |
| PFIZER | ponsegromab | Oncology |
| PFIZER | RUXIENCE * | Oncology |
| PFIZER | SYNTHOKINE | Oncology |
| PFIZER | talazoparib | Oncology |
| PFIZER | TALZENNA | Oncology |
| PFIZER | tinlorafenib | Oncology |
| PFIZER | TRAZIMERA * | Oncology |
| PFIZER | TRELSTAR | Oncology |
| PFIZER | VIZIMPRO | Oncology |
| PFIZER | XTANDI * | Oncology |
| PFIZER | ZIRABEV * | Oncology |
| PFIZER CANADA ULC | BENVYON | Oncology |
| PFIZER INC | LORBRENA | Oncology |
| PHARMACYCLICS | abexinostat | Oncology |
| PHARMACYCLICS | ibrutinib | Oncology |
| PHARMACYCLICS | IMBRUVICA * | Oncology |
| PHARMAMAR | ZEPZELCA * | Oncology |
| PHARMAMAR | ZEPZELCA * | Oncology |
| PHOSPLATIN THERAPEUTICS | imifoplatin | Oncology |
| PIERIS PHARMACEUTICALS | cinrebafusp alfa | Oncology |
| PIERRE FABRE | BRAFTOVI * | Oncology |
| PIERRE FABRE | MEKTOVI * | Oncology |
| PIQUR | bimiralisib | Oncology |
| PLUS THERAPEUTICS | rhenium (186re) obisbemeda | Oncology |
| PUMA BIOTECHNOLOGY | NERLYNX * | Oncology |
| PYRAMID BIOSCIENCES | paltimatrectinib | Oncology |
| QED THERAPEUTICS | TRUSELTIQ | Oncology |
| QILU PHARMACEUTICAL | iruplinalkib | Oncology |
| QLT USA | ELIGARD | Oncology |
| RADIUS HEALTH | elacestrant | Oncology |
| RADIUS HEALTH | vosilasarm | Oncology |
| RAFAEL PHARMACEUTICALS | devimistat | Oncology |
| RAIN THERAPEUTICS | milademetan | Oncology |
| REGENERON | davutamig | Oncology |
| REGENERON | linvoseltamab | Oncology |
| REGENERON PHARMACEUTICALS | LIBTAYO * | Oncology |
| REGENERON PHARMACEUTICALS | ubamatamab | Oncology |
| REGENERON PHARMACEUTICALS | ZALTRAP | Oncology |
| ROCHE | ALECENSARO * | Oncology |
| ROCHE | eciskafusp alfa | Oncology |
| ROCHE | forimtamig | Oncology |
| ROCHE | GAZYVA * | Oncology |
| ROCHE | imgatuzumab | Oncology |
| ROCHE | KADCYLA (カドサイラ) | Oncology |
| ROCHE | lomvastomig | Oncology |
| ROCHE | LUNSUMIO | Oncology |
| ROCHE | ROPOLIVY | Oncology |
| ROCHE | TARCEVA * | Oncology |
| ROCHE | tobemstomig | Oncology |
| ROCHE | XELODA | Oncology |
| SALARIUS | seclidemstat | Oncology |
| SALARIUS | seclidemstat mesylate | Oncology |
| SAMSUNG BIOEPIS | ONTRUZANT | Oncology |
| SAMUMED | cirtuvivint | Oncology |
| SANDOZ | RIXATHON | Oncology |
| SANDOZ | RIXIMYO | Oncology |
| SANOFI | amcenestrant | Oncology |
| SANOFI | amcenestrant | Oncology |
| SANOFI | ELIGARD | Oncology |
| SANOFI | ELITEK | Oncology |
| SANOFI | ELOXATIN | Oncology |
| SANOFI | fedratinib | Oncology |
| SANOFI | isatuximab | Oncology |
| SANOFI | JEVTANA * | Oncology |
| SANOFI | NILANDRON | Oncology |
| SANOFI | pilaralisib | Oncology |
| SANOFI | PLENAXIS * | Oncology |
| SANOFI | SARCLISA (サークリサ) | Oncology |
| SANOFI | seribantumab | Oncology |
| SANOFI | TAXOTERE | Oncology |
| SANOFI | voxtalisib | Oncology |
| SANOFI | ZALTRAP | Oncology |
| SANOFI GENZYME | gatralimab | Oncology |
| SANOFI GENZYME | vociprotafib | Oncology |
| SEAGEN | ADCETRIS (アドセトリス） * | Oncology |
| SEAGEN | denintuzumab mafodotin | Oncology |
| SEAGEN | enfortumab vedotin | Oncology |
| SEAGEN | ladiratuzumab | Oncology |
| SEAGEN | ladiratuzumab vedotin | Oncology |
| SEAGEN | sonolisib | Oncology |
| SEAGEN | TIVDAK | Oncology |
| SEAGEN | tucatinib | Oncology |
| SEAGEN | TUKYSA * | Oncology |
| SEAGEN | vadastuximab | Oncology |
| SEAGEN | vadastuximab talirine | Oncology |
| SEAGEN | vorsetuzumab mafodotin | Oncology |
| SEATTLE GENETICS | cifurtilimab | Oncology |
| SERVIER | ASPARLAS | Oncology |
| SHIONOGI PHARMA | alicdamotide | Oncology |
| SHIONOGI PHARMA | asudemotide | Oncology |
| SHIONOGI PHARMA | epertinib | Oncology |
| SHIONOGI PHARMA | trempamotide | Oncology |
| SIEMENS | flortanidazole (18f) | Oncology |
| SIEMENS | flotegatide (18f) | Oncology |
| SILLAJEN | pexastimogene devacirepvec | Oncology |
| SIRNAOMICS | lixadesiran | Oncology |
| SIRNAOMICS | pixofisiran | Oncology |
| SOLASIA | DARVIAS | Oncology |
| SPARC | vodobatinib | Oncology |
| SPARC PHARMA | bexirestrant | Oncology |
| SPECTRUM PHARMACEUTICALS | belinostat | Oncology |
| SPECTRUM PHARMACEUTICALS | BRAKIVA | Oncology |
| SPECTRUM PHARMACEUTICALS | eramkafusp alfa | Oncology |
| SPECTRUM PHARMACEUTICALS | FOLOTYN | Oncology |
| SPECTRUM PHARMACEUTICALS | FUSILEV | Oncology |
| SPECTRUM PHARMACEUTICALS | KHAPZORY | Oncology |
| SPECTRUM PHARMACEUTICALS | KYRBAX | Oncology |
| SPECTRUM PHARMACEUTICALS | MARQIBO | Oncology |
| SPECTRUM PHARMACEUTICALS | ZEVALIN | Oncology |
| ST PHARM | basroparib | Oncology |
| STADA | OYAVAS * | Oncology |
| STEMLINE THERAPEUTICS | ELZONRIS * | Oncology |
| STEMLINE THERAPEUTICS | felezonexor | Oncology |
| SUN PHARMA | INFUGEM * | Oncology |
| SUN PHARMA | INFUSMART | Oncology |
| SUN PHARMA | ODOMZO * | Oncology |
| SUN PHARMA | TACLANTIS | Oncology |
| SUNESIS PHARMACEUTICALS | QUINPREZO | Oncology |
| SUNESIS PHARMACEUTICALS | vecabrutinib | Oncology |
| SUNESIS PHARMACEUTICALS | vosaroxin | Oncology |
| SURFACE ONCOLOGY | casdozokitug | Oncology |
| SURFACE ONCOLOGY | perenostobart | Oncology |
| SURFACE ONCOLOGY | urabrelimab | Oncology |
| SYNDAX | axatilimab | Oncology |
| SYNDEVRX | evexomostat | Oncology |
| SYNTA PHARMACEUTICALS | elesclomol | Oncology |
| SYNTA PHARMACEUTICALS | rosabulin | Oncology |
| SYROS | mevociclib | Oncology |
| SYSTIMMUNE | danvilostomig | Oncology |
| TAIHO PHARMA | AROKARIS | Oncology |
| TAIHO PHARMA | LONSURF | Oncology |
| TAIHO PHARMA | TEYSUNO * | Oncology |
| TAIRX | foslinanib | Oncology |
| TAKARA BIO | canerpaturev | Oncology |
| TAKARA BIO | mipetresgene autoleucel | Oncology |
| TAKARA BIO | tebrocabtagene autoleucel | Oncology |
| TAKEDA | alisertib | Oncology |
| TAKEDA | EXKIVITY | Oncology |
| TAKEDA | imalumab | Oncology |
| TAKEDA | indusatumab | Oncology |
| TAKEDA | indusatumab vedotin | Oncology |
| TAKEDA | ixazomib | Oncology |
| TAKEDA | mivavotinib | Oncology |
| TAKEDA | mobocertinib | Oncology |
| TAKEDA | NINLARO (Нинларо) | Oncology |
| TAKEDA | orteronel | Oncology |
| TAKEDA | raxorulimogene belzovacirepvec | Oncology |
| TAKEDA | sapanisertib | Oncology |
| TAKEDA | serabelisib | Oncology |
| TAKEDA | siltocabnagene loxiveleucel | Oncology |
| TAKEDA | simurosertib | Oncology |
| TAKEDA | VELCADE | Oncology |
| TARVEDA | locnartecan | Oncology |
| TARVEDA | nendratereotide uzatansine | Oncology |
| TARVEDA | nendratereotide | Oncology |
| TELIX PHARMACEUTICALS | rosopatamab | Oncology |
| TELIX PHARMACEUTICALS | rosopatamab tetraxetan | Oncology |
| TESARO | ZEJULA | Oncology |
| TEVA PHARMACEUTICAL INDUSTRIES | BELRAPZO | Oncology |
| TEVA PHARMACEUTICAL INDUSTRIES | BENDEKA * | Oncology |
| TEVA PHARMACEUTICAL INDUSTRIES | TRUXIMA * | Oncology |
| TEVA PHARMACEUTICALS INDUSTRIES | omacetaxine mepesuccinate | Oncology |
| TEVA PHARMACEUTICALS INDUSTRIES | PAZENIR | Oncology |
| TEVA PHARMACEUTICALS INDUSTRIES | SYNRIBO * | Oncology |
| TEVA PHARMACEUTICALS INDUSTRIES | TREANDA * | Oncology |
| THERATECHNOLOGIES | sudocetaxel | Oncology |
| THERATECHNOLOGIES | sudocetaxel zendusortide | Oncology |
| THERATECHNOLOGIES | sudocetaxel zendusortide | Oncology |
| THERATECHNOLOGIES | zendusortide | Oncology |
| THRESHOLD PHARMACEUTICALS | tarloxotinib bromide | Oncology |
| TIBURIO | onzigolide | Oncology |
| TRACON PHARMACEUTICALS | carotuximab | Oncology |
| TRANSCENTA | betifisolimab | Oncology |
| TRANSCENTA | osemitamab | Oncology |
| TURNING POINT THERAPEUTICS | elzovantinib | Oncology |
| TURNING POINT THERAPEUTICS | enbezotinib | Oncology |
| TYROGENEX | vorolanib | Oncology |
| UCB | ginisortamab | Oncology |
| UNITED THERAPEUTICS | UNITUXIN | Oncology |
| UROGEN PHARMA | JELMYTO * | Oncology |
| VELOSBIO | zilovertamab | Oncology |
| VELOSBIO | zilovertamab vedotin | Oncology |
| VERTEX PHARMACEUTICALS | berzosertib | Oncology |
| VINCERX PHARMA | enitociclib | Oncology |
| VION | laromustine | Oncology |
| VOR BIOPHARMA | tremtelectogene empogeditemcel | Oncology |
| X4 PHARMACEUTICALS | mavorixafor | Oncology |
| XCOVERY | ensartinib | Oncology |
| Y-BIOLOGICS | acrixolimab | Oncology |
| Y-MABS THERAPEUTICS | DANYELZA * | Oncology |
| YM BIOSCIENCES | lexibulin | Oncology |
| ZODIAC PRODUTOS FARMACÊUTICOS | PADCEV | Oncology |
| ZYMEWORKS | zanidatamab | Oncology |
| ZYMEWORKS | zanidatamab zovodotin | Oncology |
| ZYMOGENETICS | CERVATEC | Oncology |
COVID-19 - 31